摘要 |
<p>A compound of formula (I) or a pharmaceutically acceptable derivative thereof, wherein, R<SUP>1</SUP> R<SUP>2</SUP> R<SUP>3</SUP>, R<SUP>4</SUP>, R<SUP>5</SUP>, R<SUP>6</SUP>, X and Y are as defined in the specification; a process for preparing such compounds; a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.</p> |
申请人 |
GLAXO GROUP LIMITED;BILLINTON, ANDREW;CLAYTON, NICHOLAS, MAUGHAN;GIBLIN, GERARD, MARTIN, PAUL;HEALY, MARK PATRICK |
发明人 |
BILLINTON, ANDREW;CLAYTON, NICHOLAS, MAUGHAN;GIBLIN, GERARD, MARTIN, PAUL;HEALY, MARK PATRICK |